![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C12N 7/01 | |
A61K 35/76 | |||
A61P 35/00 | |||
C07K 14/14 | |||
C12N 15/86 | |||
C12N 15/46 |
(11) | Number of the document | 2150613 |
(13) | Kind of document | T |
(96) | European patent application number | 08748334.3 |
Date of filing the European patent application | 2008-05-21 | |
(97) | Date of publication of the European application | 2010-02-10 |
(45) | Date of publication and mention of the grant of the patent | 2016-10-19 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/CA2008/000964 |
Date | 2008-05-21 |
(87) | Number | WO 2008/141448 |
Date | 2008-11-27 |
(30) | Number | Date | Country code |
939255 P | 2007-05-21 | US |
(72) |
COFFEY, Matthew C., CA
THOMPSON, Bradley G., CA
|
(73) |
Oncolytics Biotech, Inc.,
Suite 210, 1167 Kensington Crescent N.W., Calgary, Alberta T2N 1X7,
CA
|
(54) | MUTANT REOVIRUSES AND METHODS OF MAKING AND USING |
MUTANT REOVIRUSES AND METHODS OF MAKING AND USING |